drugset
drugset / Trial / NCT07484906

Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies

NCT07484906 ↗

Phase 2 Withdrawn University of New Mexico Georgia State University · collabNew Mexico VA Healthcare System · collabThe Mind Research Network · collabWashington University School of Medicine · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

PRE-EMPT will assemble a study group of 150 civilian and Veteran participants from three populations (low risk, intermediate risk, and high risk for self-harm). The investigators will obtain clinical assessments, MRI, and blood levels for circular RNA (circRNA). The teams will then administer three interventions (neurofeedback, transcranial magnetic stimulation, and psilocybin assisted therapy), and repeat the tests above. A team with expertise in artificial intelligence will then use our data to try to find patterns that identify who is at high risk versus low risk with a high degree of accuracy.

Timeline

Start
2026-05-01
Primary completion
2029-08-31
Completion
2029-08-31

Outcome

Outcome not reported

Stopped: “This is temporary withdrawal as the record was started too soon. It will be reactivated in near future.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified — —

Indications

No indication recorded.